Literature DB >> 13856609

SEQUENTIAL use of paired combinations of isoniazid, streptomycin, para-aminosalicylic acid, and pyrazinamide. A United States Public Health Service tuberculosis therapy trial.

.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS/therapy

Mesh：

Substances：

Year:  1959        PMID： 13856609     DOI： 10.1164/arrd.1959.80.5.627

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  2 in total

1.  The case for short-course chemotherapy of pulmonary tuberculosis.

Authors:  J H Angel
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

2.  Optimising pyrazinamide for the treatment of tuberculosis.

Authors:  Nan Zhang; Radojka M Savic; Martin J Boeree; Charles A Peloquin; Marc Weiner; Norbert Heinrich; Erin Bliven-Sizemore; Patrick P J Phillips; Michael Hoelscher; William Whitworth; Glenn Morlock; James Posey; Jason E Stout; William Mac Kenzie; Robert Aarnoutse; Kelly E Dooley
Journal:  Eur Respir J       Date:  2021-07-20       Impact factor: 33.795
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.